Cargando…

Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication

The COVID-19 pandemic continues to threaten healthcare systems worldwide due to the limited access to vaccines, suboptimal treatment options, and the continuous emergence of new and more transmissible SARS-CoV-2 variants. Reverse-genetics studies of viral genes and mutations have proven highly valua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fahnøe, Ulrik, Pham, Long V., Fernandez-Antunez, Carlota, Costa, Rui, Rivera-Rangel, Lizandro René, Galli, Andrea, Feng, Shan, Mikkelsen, Lotte S., Gottwein, Judith M., Scheel, Troels K. H., Ramirez, Santseharay, Bukh, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878408/ https://www.ncbi.nlm.nih.gov/pubmed/35215765 http://dx.doi.org/10.3390/v14020172

Ejemplares similares

Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication
por: Ramirez, Santseharay, et al.
Publicado: (2021)

HCV genome-wide analysis for development of efficient culture systems and unravelling of antiviral resistance in genotype 4
por: Pham, Long V., et al.
Publicado: (2022)

Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infection
por: Fossat, Nicolas, et al.
Publicado: (2023)

Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro
por: Zhou, Yuyong, et al.
Publicado: (2021)

Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro
por: Gammeltoft, Karen A., et al.
Publicado: (2021)

Productive Homologous and Non-homologous Recombination of Hepatitis C Virus in Cell Culture
por: Scheel, Troels K. H., et al.
Publicado: (2013)

Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system
por: Zhou, Yuyong, et al.
Publicado: (2022)

SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor
por: Offersgaard, Anna, et al.
Publicado: (2021)

Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19
por: Underwood, Alexander P., et al.
Publicado: (2021)

Analysis of Functional Differences between Hepatitis C Virus NS5A of Genotypes 1–7 in Infectious Cell Culture Systems
por: Scheel, Troels K. H., et al.
Publicado: (2012)

High recombination rate of hepatitis C virus revealed by a green fluorescent protein reconstitution cell system
por: Galli, Andrea, et al.
Publicado: (2021)

High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals
por: Pihl, Anne F., et al.
Publicado: (2018)

Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1–3 Strains and Does Not Correlate with Virus Replication
por: Galli, Andrea, et al.
Publicado: (2021)

Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir
por: Gammeltoft, Karen Anbro, et al.
Publicado: (2023)

Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines
por: Sølund, Christina, et al.
Publicado: (2022)

Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination
por: Underwood, Alexander P., et al.
Publicado: (2023)

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2
por: Zhou, Yuyong, et al.
Publicado: (2021)

An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals
por: Offersgaard, Anna, et al.
Publicado: (2023)

Antiviral Effect of Ribavirin against HCV Associated with Increased Frequency of G-to-A and C-to-U Transitions in Infectious Cell Culture Model
por: Galli, Andrea, et al.
Publicado: (2018)

Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization
por: Pham, Long V., et al.
Publicado: (2022)

Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine
por: Lothert, Keven, et al.
Publicado: (2020)

Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants
por: Jensen, Sanne Brun, et al.
Publicado: (2019)

Neutralization and receptor use of infectious culture–derived rat hepacivirus as a model for HCV
por: Wolfisberg, Raphael, et al.
Publicado: (2022)

Inactivated genotype 1a, 2a and 3a HCV vaccine candidates induced broadly neutralising antibodies in mice
por: Alzua, Garazi Pena, et al.
Publicado: (2023)

Characterization of a Novel Hepatitis C Virus Genotype 1 Subtype from a Patient Failing 4 Weeks of Glecaprevir-Pibrentasvir Treatment
por: Pedersen, Martin S., et al.
Publicado: (2021)

Identification of novel neutralizing determinants for protection against HCV
por: Alzua, Garazi P., et al.
Publicado: (2023)

Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure
por: Smith, David A., et al.
Publicado: (2021)

Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis
por: Tomlinson, Joy E., et al.
Publicado: (2020)

SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses
por: Christensen, Dennis, et al.
Publicado: (2023)

Virus Adaptation and Selection Following Challenge of Animals Vaccinated against Classical Swine Fever Virus
por: Fahnøe, Ulrik, et al.
Publicado: (2019)

The telomerase reverse transcriptase elongates reversed replication forks at telomeric repeats
por: Huda, Armela, et al.
Publicado: (2023)

Pathogenesis, MicroRNA‐122 Gene‐Regulation, and Protective Immune Responses After Acute Equine Hepacivirus Infection
por: Tomlinson, Joy E., et al.
Publicado: (2021)

Insights into the unique characteristics of hepatitis C virus genotype 3 revealed by development of a robust sub-genomic DBN3a replicon
por: Ward, Joseph C., et al.
Publicado: (2020)

Evolutionary selection of pestivirus variants with altered or no microRNA dependency
por: Kokkonos, Konstantinos G, et al.
Publicado: (2020)

Viral RNA pseudoknots: versatile motifs in gene expression and replication
por: Brierley, Ian, et al.
Publicado: (2007)

The Impact of Macrophage Nucleotide Pools on HIV-1 Reverse Transcription, Viral Replication, and the Development of Novel Antiviral Agents
por: Gavegnano, Christina, et al.
Publicado: (2012)

Antiviral Effects of Curcumin on Adenovirus Replication
por: Jennings, Morgan R., et al.
Publicado: (2020)

SUMOylation in Viral Replication and Antiviral Defense
por: Fan, Yao, et al.
Publicado: (2022)

Deoxynucleoside Salvage in Fission Yeast Allows Rescue of Ribonucleotide Reductase Deficiency but Not Spd1-Mediated Inhibition of Replication
por: Fleck, Oliver, et al.
Publicado: (2017)

Complete Genome Sequence of Classical Swine Fever Virus Genotype 2.2 Strain Bergen
por: Fahnøe, Ulrik, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_eujrii1p5gj594177bqea8qood